This Progressive Analyst Turns Bullish; Here Are Top 3 Upgrades For Thursday

BenzingaDec 26 09:37 ET

Express News | RAPT Therapeutics Shares up About 7% After H.c. Wainwright Upgrades to 'buy' From 'neutral' on Allergy Drug License Deal

ReutersDec 26 09:33 ET

Morning Movers: Rapt Therapeutics Rises After Upgrade

TipRanksDec 26 08:55 ET

Positive Report for RAPT Therapeutics (RAPT) From H.C. Wainwright

TipRanksDec 26 08:25 ET

Rapt Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow JonesDec 26 06:27 ET · Ratings

HC Wainwright & Co. Upgrades RAPT Therapeutics to Buy, Maintains Price Target to $10

BenzingaDec 26 06:17 ET · Ratings